Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

ETICAN

Financiado

ECM and TFEB interplay: from building multidisciplinary devices to unravelling t...

ECM and TFEB interplay: from building multidisciplinary devices to unravelling the missing link in cancer Over the last 30 years, researchers have shown that tumor cells not only need to accumulate oncogenic genetic alterations, but also rely on permissive cues from a surrounding extracellular matrix (ECM) for malignant progression. H... ver más

31/10/2025

INSTITUT GUSTAVE R...

196K€

Presupuesto del proyecto: 196K€

Líder del proyecto

INSTITUT GUSTAVE ROUSSY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-04-21

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-MSCA-2022-PF-01-01: MSCA Postdoctoral Fellowships 2022

I+D

Cerrada hace 2 años

0% 100%

1 Participantes

INSTITUT GUSTAVE ROUSSY

195.91K€ | Lider

Proyectos interesantes

PID2020-120073GB-I00 MODIFICAR LA RIGIDEZ DEL TEJIDO CANCEROSO PARA DETENER SU PR... 125K€ Cerrado

PID2020-113819RB-I00 DISEÑO DE IMPLANTES PARA TERAPIA TUMORAL Y REGENERACION OSEA... 151K€ Cerrado

PID2021-123013OB-I00 BIOMATERIALES BIOINSPIRADOS PARA MODELAR LA INTERACCION CELU... 157K€ Cerrado

PancmiR Biomimetic collagen-based scaffolds for the study of pancrea... 200K€ Cerrado

MAT2013-50036-EXP INGENIERIA DE VASOS CELULARES EN SUPERFICIE UTILIZANDO BIOIN... 63K€ Cerrado

METABOLATE METABOLic immuno-engineered biomATErials 242K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 30 meses Fecha Inicio: 2023-04-21
Fecha Fin: 2025-10-31

Líder del proyecto

INSTITUT GUSTAVE ROUSSY

TRL 4-5

Presupuesto del proyecto 196K€

Descripción del proyecto Over the last 30 years, researchers have shown that tumor cells not only need to accumulate oncogenic genetic alterations, but also rely on permissive cues from a surrounding extracellular matrix (ECM) for malignant progression. However, reconstructing the tumor niche in vitro has not been easy due to the complexity of its intertwined physico- biochemical properties and the limitation of the available biomimetic scaffolds. Furthermore, preclinical studies have mainly focused on druggable targets at the intracellular signaling level and overlooked the implication of the ECM. To overcome these hurdles, we will unravel the ECM mechano-chemical contribution in tumorigenesis and its continuum interaction with tumor cells in 3 steps. First, we will deconstruct bladder cancer ECM through in-depth analysis of its physical and biochemical features. This will provide us a blueprint to follow, in order to build a tailored microenvironment for bladder tumoroids. Then, we will reassemble ECM properties in a new generation of tunable materials, functionalized with ECM proteins secreted by bladder cancer cells in vitro. Using our developed tumoroid model, we will finally chart the reciprocal crosstalk between extracellular cues and transcription factor EB (TFEB), an emerging oncogene and regulator of tumor microenvironment. By bridging the gap between ECM and TFEB regulation, we anticipate to catalyse the success of cancer prevention and therapy leveraging new druggable targets at the level of the reciprocal feedback between the evolving ECM and tumor cells.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores